Market Insights Health Medical Technology Medical Devices

General & Plastic Surgery Devices - China

China

The General & Plastic Surgery Devices market market in China is expected to experience significant growth in the coming years.
According to projections, the revenue in this market is set to reach US$1.72bn in 2024.
Moreover, it is anticipated that the market will continue to expand at an annual growth rate of 7.18% from 2024 to 2028.
By the end of 2028, the market volume is estimated to reach US$2.27bn.
When compared globally, the United States is predicted to generate the highest revenue in the General & Plastic Surgery Devices market market.
In 2024, the revenue the United States is projected to reach an impressive US$10,150.00m.
China's rapidly aging population and increasing disposable income have fueled a surge in demand for advanced plastic surgery devices.

Key regions: China, Japan, Italy, United States, Netherlands

Market

Region

Region comparison

Currency

Analyst Opinion

The General & Plastic Surgery Devices market in China has been experiencing significant growth in recent years, driven by various factors such as increasing customer preferences for aesthetic procedures, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. Customer preferences in China have been shifting towards a greater emphasis on appearance and self-improvement. As the country's middle class continues to grow, there is a rising demand for cosmetic surgeries and procedures to enhance physical features. Additionally, the influence of social media and celebrity culture has played a role in shaping customer preferences, as individuals aspire to achieve certain beauty standards. Trends in the market indicate a growing demand for minimally invasive procedures and non-surgical treatments. This can be attributed to factors such as the desire for quicker recovery times, lower costs, and less invasive procedures. Technological advancements in the General & Plastic Surgery Devices industry have made these procedures more accessible and affordable, further driving their popularity. Local special circumstances in China have also contributed to the development of the General & Plastic Surgery Devices market. The country's aging population has created a demand for anti-aging procedures and treatments. Additionally, the one-child policy implemented in the past has led to a generation of individuals who are financially capable and willing to invest in cosmetic procedures. Underlying macroeconomic factors have also played a role in the growth of the General & Plastic Surgery Devices market in China. The country's rapid economic development has resulted in increased disposable income, allowing individuals to afford aesthetic procedures. Furthermore, the government's push for healthcare reform and investment in medical infrastructure has improved access to healthcare services, including cosmetic surgeries and treatments. In conclusion, the General & Plastic Surgery Devices market in China is experiencing significant growth due to shifting customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. As the demand for aesthetic procedures continues to rise, it is expected that the market will further expand in the coming years.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.